title: Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancer.
authors.forename: P
authors.initials: P
authors.lastname: Rougier
authors.forename: G G
authors.initials: GG
authors.lastname: Chabot
authors.forename: J
authors.initials: J
authors.lastname: Bonneterre
authors.forename: J M
authors.initials: JM
authors.lastname: Tigaud
authors.forename: C
authors.initials: C
authors.lastname: Lucas
authors.forename: M
authors.initials: M
authors.lastname: Baud
authors.forename: J
authors.initials: J
authors.lastname: Bérille
authors.forename: A
authors.initials: A
authors.lastname: Gouyette
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D009943:Organophosphorus Compounds; C054368:fotemustine